|
|
||||||||
Articles |
Embolotherapy for nonneoplastic vascular diseases including hemorrhage and congenital vascular malformations is reviewed. Application of short, intermediate, and long-acting embolic materials to these conditions is presented along with potential complications associated with their misuse. Successful application of embolotherapy results from a thorough understanding of the disease process being treated, the distinctive features of the circulation to be embolized, and the embolic material used for the occlusion.
This article has been cited by other articles:
![]() |
J. R. GOSSAGE and G. KANJ Pulmonary Arteriovenous Malformations . A State of the Art Review Am. J. Respir. Crit. Care Med., August 1, 1998; 158(2): 643 - 661. [Full Text] [PDF] |
||||
![]() |
S. M. Winter and D. H. Ingbar Massive Hemoptysis: Pathogenesis and Management J Intensive Care Med, May 1, 1988; 3(3): 171 - 188. [Abstract] [PDF] |
||||
![]() |
A. H. Boyarsky, M. F. Sabado, K. P. Sheka, D. H. Gordon, and B. L. Herz Residual Aorto-Caval Fistula: Treatment by Embolotherapy A Case Report Vascular and Endovascular Surgery, November 1, 1987; 21(6): 440 - 443. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |